P
Pacific Biosciences of California, Inc.
PACB · NASDAQ · Healthcare · 357M
Price · close
$1.35
+9.76% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
75.7×
Enterprise value / EBITDAEV/EBITDA
-32.2×
Free cash flow yieldFCF yield
-28.1%
Return on equityROE
-10214.5%
Operating margin
-348.5%
Net debt / EBITDAbalance-sheet strength
-20.3×
Interest coverage
-80.2×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.